[EN] CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS [FR] PYRIDONES CYCLOALKYLE PYRAZOLO NITRILE EN TANT QU'INHIBITEURS DE JANUS KINASE
[EN] CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS<br/>[FR] CYCLOALKYLNITRILE PYRAZOLOPYRIDONES UTILISÉES COMME INHIBITEURS DE LA JANUS KINASE
申请人:MERCK SHARP & DOHME
公开号:WO2014146490A1
公开(公告)日:2014-09-25
Compounds of formula I are provided, which are JAK inhibitors and are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS
申请人:Wyeth LLC
公开号:EP2229377A1
公开(公告)日:2010-09-22
CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS
申请人:Merck Sharp & Dohme Corp.
公开号:EP2976340A1
公开(公告)日:2016-01-27
US9725445B2
申请人:——
公开号:US9725445B2
公开(公告)日:2017-08-08
[EN] 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS<br/>[FR] 5-ALKYL/ALCÉNYL-3-CYANOPYRIDINES EN TANT QU'INHIBITEURS DE KINASE
申请人:WYETH CORP
公开号:WO2009076602A1
公开(公告)日:2009-06-18
Described herein are compounds of formula I: wherein G is and pharmaceutically acceptable salts thereof, wherein J, X, R1, R2, R11, R12' and p are as defined herein. Also provided herein are methods of making the compounds of formula I, and methods of using these compounds for inhibiting or treating a pathological condition or disorder linked to or mediated by a protein kinase in a mammal.